Skip to main content
. Author manuscript; available in PMC: 2020 Jun 19.
Published in final edited form as: Expert Rev Cardiovasc Ther. 2013 Feb;11(2):161–177. doi: 10.1586/erc.12.191
• Potential indications
 – Dyspnea at rest or with exertion
 – Inspiratory muscle weakness (<70% of the predicted value)
 – Pulmonary hypertension
• Potential contraindications
 – Markedly elevated left ventricular end-diastolic volume and pressure
 – Worsening heart failure signs and symptoms after IMT is initiated
 – Desaturation with IMT
 – Paradoxical breathing pattern
 – Worsening inspiratory muscle performance,§
 – Persistent diaphragmatic/abdominal/thoracic/inspiratory accessory muscle discomfort

Modify IMT prescription if observed.

Consider providing supplemental oxygen if oxygen saturation is observed to decrease from resting levels.

§

Worsening inspiratory muscle performance defined as an inability to repeatedly achieve MIP, sustained MIP, inspiratory endurance or inspiratory duration achieved during previous IMT sessions.

IMT: Inspiratory muscle training; MIP: Maximal inspiratory pressure.